165 related articles for article (PubMed ID: 27299829)
1. [Bone involvement in systemic mastocytosis: Report of two cases].
Florenzano P; Mezzano V; Le-Bert M; González G
Rev Med Chil; 2016 Mar; 144(3):401-5. PubMed ID: 27299829
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for fragility fracture in systemic mastocytosis.
Degboé Y; Eischen M; Nigon D; Apoil PA; Mailhol C; Tournier E; Laurent C; Hanssens K; Hermine O; Paul C; Laroche M; Bulai-Livideanu C
Bone; 2017 Dec; 105():219-225. PubMed ID: 28919366
[TBL] [Abstract][Full Text] [Related]
3. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre.
Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA
Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
[TBL] [Abstract][Full Text] [Related]
5. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
6. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
7. Mastocytosis with urticaria pigmentosa and osteoporosis.
Stein JA; Kamino H; Walters RF; Pomeranz MK
Dermatol Online J; 2008 Oct; 14(10):2. PubMed ID: 19061601
[TBL] [Abstract][Full Text] [Related]
8. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
[TBL] [Abstract][Full Text] [Related]
9. Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.
Degboé Y; Eischen M; Apoil PA; Mailhol C; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C; Laroche M
Osteoporos Int; 2019 Jun; 30(6):1235-1241. PubMed ID: 30847528
[TBL] [Abstract][Full Text] [Related]
10. Bone lesions in systemic mastocytosis: Bone histomorphometry and histopathological mechanisms.
Bouvard B; Pascaretti-Grizon F; Legrand E; Lavigne C; Audran M; Chappard D
Morphologie; 2020 May; 104(345):97-108. PubMed ID: 32127247
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: a report of two cases.
Manara M; Varenna M; Cantoni S; Parafioriti A; Gallazzi MB; Sinigaglia L
Clin Exp Rheumatol; 2010; 28(1):97-100. PubMed ID: 20346248
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis as the sole manifestation of systemic mastocytosis in a young man.
Abramowitz JD; Weinerman SA
Endocr Pract; 2012; 18(6):e158-61. PubMed ID: 23246689
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review.
Horny HP; Sotlar K; Valent P
Pathobiology; 2010; 77(4):169-80. PubMed ID: 20616612
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase.
Potier A; Lavigne C; Chappard D; Verret JL; Chevailler A; Nicolie B; Drouet M
Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252
[TBL] [Abstract][Full Text] [Related]
15. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
[TBL] [Abstract][Full Text] [Related]
16. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study.
Chines A; Pacifici R; Avioli LV; Teitelbaum SL; Korenblat PE
J Clin Endocrinol Metab; 1991 Jan; 72(1):140-4. PubMed ID: 1986013
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.
van der Veer E; van der Goot W; de Monchy JG; Kluin-Nelemans HC; van Doormaal JJ
Allergy; 2012 Mar; 67(3):431-8. PubMed ID: 22229787
[TBL] [Abstract][Full Text] [Related]
18. Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study.
Broesby-Olsen S; Farkas DK; Vestergaard H; Hermann AP; Møller MB; Mortz CG; Kristensen TK; Bindslev-Jensen C; Sørensen HT; Frederiksen H
Am J Hematol; 2016 Nov; 91(11):1069-1075. PubMed ID: 27428296
[TBL] [Abstract][Full Text] [Related]
19. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
